# Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration

> **NCT01923961** · NA · COMPLETED · sponsor: **EXcorLab GmbH** · enrollment: 8 (actual)

## Conditions studied

- End-stage Renal Disease

## Interventions

- **PROCEDURE:** HDF NaCl
- **PROCEDURE:** Hemodialysis
- **PROCEDURE:** Standard Predilution Hemodiafiltration

## Key facts

- **NCT ID:** NCT01923961
- **Lead sponsor:** EXcorLab GmbH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-03-30
- **Final completion:** 2015-08-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923961, "Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT01923961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*